Pan‑Acetyllysine Antibodies: Broad‑Spectrum Probes for Global Lysine‑Acetylation Proteome Investigation

Pan‑Acetyllysine Antibodies: Broad‑Spectrum Probes for Global Lysine‑Acetylation Proteome Investigation

Core Concept: Pan‑Acetyllysine Antibodies Compared With Site‑Specific Acetylation Reagents

Lysine acetylation represents a pervasive post‑translational modification occurring on both histone and non‑histone eukaryotic proteins. This chemical alteration remodels protein charge, tertiary conformation, molecular‑partner interaction and biological activity across transcription, metabolism and cell‑cycle regulatory networks. Site‑specific acetyl‑modification antibodies recognize acetylated residues together with surrounding fixed amino‑acid sequences of one defined protein locus. In contrast, pan‑acetyllysine antibodies selectively target the acetyl‑modified lysine moiety itself, largely independent of adjacent polypeptide sequence context. Immunization typically uses chemically acetylated carrier proteins such as acetylated ovalbumin or BSA followed by multi‑step affinity‑purification workflows. Pan‑modification reagents answer questions about global acetyl‑landscape shifts, while site‑specific clones validate acetylation status at individual protein residues. These two antibody categories function as complementary analytical tools covering untargeted screening and precise locus‑oriented verification respectively.

Key Performance Metrics for Evaluating Pan‑Acetyllysine Antibody Quality

Several measurable performance indicators determine whether pan‑acetyllysine antibodies deliver trustworthy data in complex biological‑sample matrices. Modification specificity ranks highest among these benchmarks, as lysine can receive structurally similar acyl‑group modifications including propionylation and butyrylation. Reliable batches generate far stronger binding signals for acetyl‑lysine epitopes relative to propionyl‑ or butyryl‑lysine peptide substrates. Some validated preparations exhibit greater than 500‑fold selectivity for acetylated substrates compared with corresponding unmodified peptide controls. Titer values define antibody sensitivity and report acceptable working dilution ranges for distinct experimental readouts. Species‑cross‑reactivity profiles document compatibility across human, murine and other model‑organism sample material. Researchers should examine full validation datasets before selecting reagents for acetylome‑proteomics experimental pipelines.

Core Experimental Workflows Enabled by Pan‑Acetyllysine Antibody Reagents

Pan‑acetyllysine antibodies serve as foundational probes throughout multiple phases of lysine‑acetylation‑oriented basic‑research projects. Western‑blot profiling enables straightforward comparative measurement of total‑protein acetylation levels between compound‑treated and control cell or tissue lysate groups. For proteomic discovery workflows, these antibodies conduct immuno‑enrichment of acetylated peptides or full‑length acetyl‑proteins out of digested or native lysate mixtures. Captured material is then submitted to LC‑MS/MS mass spectrometry to construct system‑wide acetylome maps and identify previously‑unknown acetylation substrates and sites. During phenotypic screening campaigns, immunoblot readouts rapidly detect obvious global acetylation alterations triggered by genetic or pharmacological perturbation. Interesting candidate bands observed in screening can be excised and further characterized via mass‑spectrometry for downstream mechanistic follow‑up investigation. Pan‑acetyllysine tools generate preliminary screening leads that are subsequently confirmed with locus‑specific modification‑targeted antibody clones.

Experimental Considerations for Reproducible Pan‑Acetyllysine Assay Outcomes

Certain technical pitfalls may distort results when probing global acetylation landscapes using pan‑acetyllysine immunological reagents. Endogenous histone‑deacetylase enzyme activity during cell lysis can remove acetyl groups from substrate proteins before sample fixation, requiring HDAC inhibitor supplementation in lysis buffers. Non‑fat milk blocking solutions contain endogenous acetylated proteins and may introduce high background; 5 % BSA blocking buffer is generally recommended instead. Peptide‑competition control reactions should be included to distinguish genuine acetyl‑lysine‑derived signals from non‑specific antibody off‑target binding artifacts. For peptide‑enrichment‑coupled mass‑spectrometry workflows, bead‑conjugated anti‑acetyllysine affinity resins streamline high‑throughput sample‑handling operations. Thoughtful experimental controls greatly improve confidence in observed acetyl‑proteome differences between comparative biological cohorts.

屏幕截图 2026-08-11 085518.png

Research Outlook for Global Lysine‑Acetylation Proteomics

Contemporary acetylome research continues expanding into diverse biological contexts ranging from central‑carbon metabolism to host‑pathogen immune‑response signalling. Multi‑omics strategies combine acetylome datasets with transcriptomic, ubiquitin‑proteomic and metabolomic measurements to decode layered PTM‑metabolism crosstalk networks. High‑quality pan‑modification antibodies and matching immuno‑affinity beads remain irreplaceable for unbiased discovery‑phase acetyl‑proteomic profiling. Subsequent validation steps deploy site‑specific antibodies to confirm biologically relevant acetylation events on individual target‑protein molecules. This combined screening‑plus‑validation workflow builds robust mechanistic models describing how lysine‑acetylation reshapes cellular physiological outputs under changing environmental or pharmacological conditions.

Pan‑Acetyllysine Research Reagents from ANT BIO PTE. LTD

ANT BIO PTE. LTD provides S0B0655 Acetyllysine Rabbit polyclonal antibody together with S0F0004 anti‑acetyllysine agarose affinity beads for pan‑acetylation‑oriented basic‑research assays. Every reagent batch completes peptide‑array specificity profiling and multi‑application functional verification prior to commercial distribution.

Catalog Table of Pan‑Acetyllysine Detection Reagents

Catalog Number Full Product Name Core Product Specifications Available Pack Sizes
S0B0655 Acetyllysine Rabbit polyclonal antibody Unconjugated rabbit polyclonal pan‑acetyllysine antibody 25 μL / 100 μL / 1 mL
S0F0004 Anti‑acetyllysine agarose Beads Anti‑acetyllysine antibody covalently coupled cross‑linked agarose resin 300 μL / 1 mL

Functional‑Validation Characteristics of ANT BIO PTE. LTD Acetyl‑Lysine Reagents

S0B0655 polyclonal antibody recognizes acetyl‑lysine largely independent of surrounding peptide‑sequence backgrounds and shows limited cross‑reactivity toward propionylated or butyrylated lysine epitopes. Matching S0F0004 agarose beads transfer this epitope‑selectivity to solid‑phase enrichment workflows for peptide or full‑length‑protein pull‑down experiments. Validated sample matrices include mammalian cell‑line lysates, tissue homogenates and immunoprecipitated protein‑complex preparations. Qualified compatible experimental workflows include quantitative Western blot, immunoprecipitation enrichment, peptide pull‑down and LC‑MS‑coupled global acetylome‑profiling pipelines.

Core Fundamental‑Research Applications for Pan‑Acetyllysine Reagent Panel

  1. Comparative Western‑blot quantification of global lysine‑acetylation shifts under HDAC‑inhibitor or genetic‑perturbation experimental conditions

  2. Immuno‑affinity enrichment of acetylated peptide pools for large‑scale LC‑MS/MS‑based acetylome proteomic profiling

  3. Immunoprecipitation capture of full‑length acetylated protein complexes to characterize acetylation‑dependent protein‑protein‑interaction networks

  4. High‑throughput phenotypic screening identifying treatment groups displaying prominent global‑acetylation‑landscape rearrangements

  5. Multi‑omics experimental workflows dissecting crosstalk between lysine acetylation, ubiquitination and cellular metabolic signalling pathways

  6. Orthogonal preliminary screening generating candidate targets for downstream validation utilizing site‑specific acetylation‑directed antibody clones

Global Manufacturing & Compliance Standards

All pan‑acetyllysine antibody and immuno‑affinity bead batches complete peptide‑specificity screening and multi‑platform functional verification before commercial‑product release. Manufacturing facilities adhere to ISO9001, ISO13485 and EU 98/79/EC certification specifications governing life‑science‑research‑reagent production protocols. In‑house application‑science teams supply optimized lysis‑buffer recommendations, assay SOP documents and curated lysine‑acetylation‑proteomics reference‑publication resources. The broader reagent ecosystem integrates other PTM‑specific antibodies, ELISA kits and magnetic separation beads to support comprehensive multi‑omics molecular‑cell‑biology‑research pipelines.


ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high‑quality, reliable reagents and comprehensive solutions. Our specialized sub‑brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer‑centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.


Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.